Compounded with
Semaglutide
Not verified in the bound record.
Tirzepatide
Not verified in the bound record.
Product evidence does not establish current availability.
Pharmacy evidence record · researched 2026-08-20
Ajijo Inc. dba Lewisville Medical Pharmacy / Luxe Med Compounding
Not verified in the bound record.
Not verified in the bound record.
Product evidence does not establish current availability.
Regulatory compliance
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
traditional patient pharmacy compounding verified 503a not explicitly verified
Section 503B
not found in current fda registry check
Telehealth providers
Clinic Scout links a provider only when an explicit source names the relationship.
Regulatory history
FDA warning-letter/Form 483/current-503B and Texas disciplinary-summary sources were checked. No matching action was found in the bounded search; this is not a claim that none exists.
No regulatory action was found in the bounded search. That is not a categorical absence claim.
No Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.
What this record verifies for you
Each line traces to a citation in the source list below — read the exact captured wording before relying on it.
No superiority claim is made for review volume, ratings, or patient sentiment.
Luxe Med Compounding Pharmacy is a full-service independent pharmacy in Lewisville, TX
Compounding allows us to create custom medications specifically for you
Legal Name: AJIJO INC, Doing Business As: LEWISVILLE MEDICAL PHARMACY, LUXE MED COMPOUNDING, Address: 560 W MAIN ST STE 105 LEWISVILLE, TX 75057-3665
Updated as of 8/18/2026 ... This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 4 dated first-party or regulator citation(s), 0 regulatory/action record(s), and 6 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.
Weekly price watch
One useful comparison each week. No spam, no sold lists, and you can unsubscribe anytime.